|
TCRT Alaunos Therapeutics Inc 1107421 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-1,006,000.00 |
| Balance Sheet |
|
Current Assets
|
$970,000.00 |
|
Assets
|
$1,883,000.00 |
|
Current Liabilities
|
$595,000.00 |
|
Liabilities
|
$595,000.00 |
|
Equity
|
$1,288,000.00 |
|
Shares Out
|
2378383.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,031,000.00 |
|
Investing Cash Flow
|
$-98,000.00 |
| Market Analysis |
Market Cap
|
$4,471,360.04 |
|
Price
|
$1.88 |
|
BVPS
|
0.54 |
|
PB
|
3.48 |
|
EPS
|
-0.59 |
|
FCF
|
$-1,129,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TCRT documents filed with the SEC.
TCRT Filings
Clear
